{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:04:36Z","timestamp":1785683076740,"version":"3.56.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2253,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1365-2133.2009.09147.x","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T14:02:42Z","timestamp":1239890562000},"page":"121-127","source":"Crossref","is-referenced-by-count":52,"title":["Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders"],"prefix":"10.1093","volume":"161","author":[{"given":"M.F.","family":"Benner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB2","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1309\/R2Q9CCUVTLRYCF3H","article-title":"Anaplastic large cell lymphoma","volume":"127","author":"Medeiros","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB5","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB6","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/sj.jid.5700800","article-title":"Differential expression of TRAF1 aids in the distinction of cutaneous CD30-positive lymphoproliferations","volume":"127","author":"Assaf","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB7","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1365-2133.2008.08566.x","article-title":"MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"158","author":"Kempf","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0046-8177(98)90249-0","article-title":"Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily","volume":"29","author":"Paulli","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.humpath.2007.08.013","article-title":"The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders","volume":"39","author":"Wasco","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB10","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/blood.V93.2.617","article-title":"Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin\u2019s disease and Epstein-Barr virus-transformed lymphoid cells","volume":"93","author":"Durkop","year":"1999","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.pas.0000149689.75462.ff","article-title":"TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas","volume":"29","author":"Rodig","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB13","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.4049\/jimmunol.165.9.5084","article-title":"TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies","volume":"165","author":"Zapata","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB14","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V95.6.2084","article-title":"A monoclonal antibody (MUM1p) detects expression of the MUM1\/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells","volume":"95","author":"Falini","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng1097-226","article-title":"Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma","volume":"17","author":"Iida","year":"1997","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.leu.2401696","article-title":"MUM1\/IRF4 expression as a frequent event in mature lymphoid malignancies","volume":"14","author":"Tsuboi","year":"2000","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3324\/haematol.11523","article-title":"A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin\u2019s lymphoma: a potential prognostic role of MUM1\/IRF4","volume":"92","author":"Valsami","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2133.2007.07933.x","article-title":"Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study","volume":"157","author":"Goteri","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1600-0560.1997.tb01319.x","article-title":"p53 and bcl-2 expression do not correlate with prognosis in primary cutaneous large T-cell lymphomas","volume":"24","author":"van Haselen","year":"1997","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB21","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/1097-0142(19921201)70:11<2691::AID-CNCR2820701121>3.0.CO;2-2","article-title":"Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas","volume":"70","author":"Carbone","year":"1992","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB22","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB23","first-page":"319","article-title":"CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis","volume":"22","author":"Gorczyca","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAP.0b013e3180ca8a49","article-title":"Diagnostic uses of Pax5 immunohistochemistry","volume":"14","author":"Feldman","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"10.1111\/j.1365-2133.2009.09147.x-BIB25","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/00000478-199810000-00004","article-title":"Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases","volume":"22","author":"Vergier","year":"1998","journal-title":"Am J Surg Pathol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09147.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09147.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T21:05:40Z","timestamp":1684962340000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/161\/1\/121\/6642098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09147.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}